Skip to content
Hantavirus.Watcher
Menu
← Back to ledger
OutbreakPublished Jun 1 · 2026AI-classified · awaiting human verification

Hantavirus outbreak linked to cruise ship travel, Multi-locations

Read original atwho.int

CanadaConfidence 95%13 affectedToday

A WHO Disease Outbreak News report updates on the Andes hantavirus outbreak linked to the M/V Hondius cruise ship, reporting 13 cases and three deaths, with new cases confirmed in Canada, the Netherlands, and Spain.

Source articles

Every claim above is derived from publicly available reporting. Click through to read the original at the publisher.

  • Primary
    Hantavirus outbreak linked to cruise ship travel, Multi-locations

    who.int · 2026-06-01

    This is the fourth WHO Disease Outbreak News report on the Andes hantavirus outbreak linked to the M/V Hondius cruise ship. As of May 27, 2026, a total of 13 cases, including three deaths, have been reported, with additional confirmed cases in Canada, the Netherlands, and Spain. The outbreak is believed to have originated from a case acquiring infection prior to boarding in South America, with subsequent human-to-human transmission onboard the ship.

  • Reference
    Hantavirus outbreak linked to cruise ship travel, Multi-locations

    who.int · 2026-06-01

    The World Health Organization (WHO) reported on May 28, 2026, that the Andes hantavirus outbreak linked to the M/V Hondius cruise ship has resulted in 13 cases (11 confirmed, 2 probable) and three deaths as of May 27. New confirmed cases were identified in Canada, the Netherlands, and Spain. The Andes virus, endemic in South America (Argentina, Chile, Uruguay, Brazil, Paraguay), is known for limited human-to-human transmission. Over 600 contacts across 32 countries are being traced and monitored. Passengers disembarked in Saint Helena, Ascension, Praia (Cabo Verde), and Tenerife (Spain).

Reminder

This report is an aggregated summary of public information for surveillance and awareness purposes only. It is not medical advice. For symptoms, exposure, or clinical decisions, contact a qualified clinician or your local public-health authority.